About NanoString Technologies, Inc.

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications.

NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection. In 2019, the company launched the GeoMx™ Digital Spatial Profiler enabling highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. In 2022, the company launched CosMxTM Spatial Molecular Imager, enabling the first high-plex in situ analysis platform to provide spatial multi-omics with formalin-fixed paraffin-embedded (FFPE) and fresh frozen (FF) tissue samples at cellular and subcellular resolution. CosMx SMI is a flexible, spatial single-cell imaging platform that will drive deeper insights for cell atlasing, tissue phenotyping, cell-cell interactions, cellular processes, and biomarker discovery. In 2022, AtoMx™ Spatial Informatics Platform (SIP), the only cloud-based, fully-integrated informatics platform for spatial biology, was also launched.

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
530 Fairview Avenue N, Suite 2000, Seattle, WA 98109, US
description icon
Founded
2003
description icon
Keywords
Gene Expression, Mirna, Cnv And Single Cell Analysis, Digital Genomics For Pathway-Based Research, General Purpose Reagents For Laboratory Use, Multiplexed Molecular Diagnostic Development, Translational Cancer Genomics And Cancer Research

NanoString Technologies, Inc. Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about NanoString Technologies, Inc.

Who is the CEO of NanoString Technologies, Inc.?

Trish Potter is the CEO of NanoString Technologies, Inc.. To contact Trish Potter email at [email protected] or [email protected].

Who are the decision makers in NanoString Technologies, Inc.?

The decision makers in NanoString Technologies, Inc. are Alejandro Salgado Gil, Brad Gray, Diane Hu Lince, etc. Click to Find NanoString Technologies, Inc. decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more